HV Electrophysiology Study In Transcatheter Aortic Valve Implantation Patients

Completed

• Conditions: Cardiac conduction disease; 10007521; Left Bundle Branch Block

• Registration Number: NL-OMON43555
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

All patients undergoing a TAVI procedure.

Exclusion Criteria

-Pre-existent LBBB
-Pre-existent sick sinus syndrome
-Pre-existing high-degree atrioventricular block
-Pre-existent permanent pacemaker
-Patients unable to provide written informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Occurrence of a new LBBB. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-Symptomatic or asymptomatic high degree atrioventricular conduction disorder,<br /><br>defined as: asystole >5 seconds, second degree Mobitz-II block or third degree<br /><br>atrioventricular block.<br /><br>-Pacemaker implantation.</p><br>